Data gathered: July 3
AI Stock Analysis - iRhythm Technologies (IRTC)
Analysis generated June 29, 2024. Powered by Chat GPT.
iRhythm Technologies is a digital healthcare company specializing in the development and commercialization of advanced remote monitoring and diagnostic solutions for cardiac arrhythmias. The company leverages innovative technologies to improve patient care by providing timely and comprehensive diagnostic services. Their flagship product, the Zio by iRhythm service, has made significant strides in enabling better diagnosis and treatment of arrhythmic conditions.
Stock Alerts - iRhythm Technologies (IRTC)
 |
iRhythm Technologies | July 3 Insider Alert: Turakhia Minang is selling shares |
|
iRhythm Technologies | June 25 Insider Alert: Wilson Daniel G. is selling shares |
|
iRhythm Technologies | June 4 Insider Alert: Shrishrimal Sumi is selling shares |
|
iRhythm Technologies | June 3 Employee Rating is up by 3.6% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for iRhythm Technologies
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 83 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 117,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | 24 | Sign up | Sign up | Sign up |
| Patents | 55 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,603 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,539 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,609 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 42 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,653 | Sign up | Sign up | Sign up |
About iRhythm Technologies
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities.
| Price | $142.47 |
| Target Price | Sign up |
| Volume | 206,870 |
| Market Cap | $4.66B |
| Year Range | $72.44 - $154.71 |
| Dividend Yield | 0% |
| Analyst Rating | 80% buy |
| Industry | Medical & Dental Instruments |
In the news
 |
Morgan Stanley Raises iRhythm (IRTC) Price Target, Maintains Overweight RatingJuly 3 - Biztoc.com |
 |
Diversified Trust Co Grows Stock Holdings in iRhythm Technologies (NASDAQ:IRTC)June 30 - ETF Daily News |
 |
Patient Monitoring Stocks Q1 In Review: iRhythm (NASDAQ:IRTC) Vs PeersJune 29 - Yahoo |
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTCJune 27 - Finnhub |
|
|
3 Reasons IRTC is Risky and 1 Stock to Buy InsteadJune 26 - Yahoo |
|
DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health?June 18 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 159M | 49M | 109M | -31M | -33M | -0.950 |
| Q4 '24 | 164M | 49M | 115M | -1.3M | 8.7M | 0.010 |
| Q3 '24 | 148M | 46M | 101M | -46M | -36M | -1.260 |
| Q2 '24 | 148M | 45M | 103M | -20M | -10M | -0.610 |
| Q1 '24 | 132M | 44M | 88M | -46M | -36M | -1.230 |
Insider Transactions View All
| Turakhia Minang filed to sell 41,393 shares at $145.4. July 2 '25 |
| Patterson Chad filed to sell 48,929 shares at $150. June 24 '25 |
| Wilson Daniel G. filed to sell 40,307 shares at $150. June 24 '25 |
| Patterson Chad filed to sell 49,865 shares at $150. June 11 '25 |
| Rosenbaum Marc W. filed to sell 11,105 shares at $140.2. June 3 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$196.84 0.1% | 43 |
 |
DentsplyXRAY |
$16.67 0.6% | 41 |
 |
LeMaitre VascularLMAT |
$84.39 0.6% | 37 |
 |
NovoCureNVCR |
$17.75 0.7% | 43 |
 |
DanaherDHR |
$203.76 0.6% | 31 |
Read more about iRhythm Technologies (IRTC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of iRhythm Technologies?
The Market Cap of iRhythm Technologies is $4.66B.
What is the current stock price of iRhythm Technologies?
Currently, the price of one share of iRhythm Technologies stock is $142.47.
How can I analyze the IRTC stock price chart for investment decisions?
The IRTC stock price chart above provides a comprehensive visual representation of iRhythm Technologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling iRhythm Technologies shares. Our platform offers an up-to-date IRTC stock price chart, along with technical data analysis and alternative data insights.
Does IRTC offer dividends to its shareholders?
As of our latest update, iRhythm Technologies (IRTC) does not offer dividends to its shareholders. Investors interested in iRhythm Technologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of iRhythm Technologies?
Some of the similar stocks of iRhythm Technologies are Align Technology, Dentsply, LeMaitre Vascular, NovoCure, and Danaher.
.